BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 03/04/2015

FDA Extends Comment Period for Biomarker Notice

The FDA is extending the comment period for a notice on identifying potential biomarkers for drug development, giving interested persons more time to submit comments.

Source: Federal Register — Food and Drug AdministrationOpen original release →